-- Open access to Philips imaging technologies allows researchers
to develop advanced MR solutions to expand access to more
patients
ANDOVER,
Mass./PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA) today
announced the range of its Magnetic Resonance (MR) solutions to be
showcased at the International Society
for Magnetic Resonance in Medicine's
(ISMRM) 23rd Annual Meeting &
Exhibition in Toronto,
Canada. Visitors to Philips booth
#301 will see the latest in innovations designed in
collaboration with clinicians and partners, to increase clinical
performance, enhance patient experience and provide economic value.
The solutions highlight Philips' commitment to making MR more
accessible to patients, while improving diagnostic confidence.
Logo
- http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
"MR
brings the best of cutting edge technologies and clinical
applications in a robust way to address real world clinical
challenges and disease states for people around the globe in
multiple care settings across the health continuum,"
said Vinay
Parthan, VP Research and Development MRI, Philips. "MR is
also a nascent imaging modality and has tremendous scope for
research and exploration. Philips is excited to collaborate with
our research partners as we co-innovate to enhance patient care
through intuitive and quantitative MR."
With
acquisition, reconstruction and post processing research tools like
Paradise Pulse Programming environment and Recon 2.0, Philips
provides research partners access to key algorithms within its MR
systems, allowing them to develop their own applications on Philips
platforms.
"Our
group has had a longstanding collaboration with Philips. A
significant contributor to the success of this collaboration has
been the ability to access their MR software source code, which has
allowed us to delve deep into the system and create new imaging
techniques to help with stroke research." said
Dr. Chun
Yuan, Ph.D., Professor in Radiology and
Bioengineering, University
of Washington, Seattle, U.S.A.,
and Professor and Director of Center for Biomedical Imaging
Research, Tsinghua University, Beijing,
China. "Ultimately, we believe this will help us to create
new clinical methods to diagnose and treat patients at risk of
having stroke before it happens."
The
Philips ISMRM Booth #301 will feature the following research-only
technologies:
Philips Recon 2.0* – Flexible, high-end MR image
reconstruction framework
IntelliSpace Discovery* – Multi-modality visualization
and analysis solution to facilitate research
The
booth will also feature the following solution:
Ingenia MR-RT
MR-only simulation** – New approach in therapy that helps
clinicians rely on MR as a primary imaging modality for prostate
cancer treatment.
And
the following commercially available product:
Ingenia 3.0T
CX – Designed to help you to explore new clinical fields
with confidence, perform advanced clinical imaging to supports
referrals and conduct routine imaging efficiently
For
more information on Philips' presence at ISMRM, stop by the Philips
booth #301, visitwww.philips.com/ISMRM and follow the
conversation on @PhilipsHealth.
For further information, please
contact:
Kathy
O'Reilly
Philips Group Communications
(mobile) +1-978-221-8919
Kathy.oreilly@philips.com
Twitter: @kathyoreilly
About Royal
Philips:
Royal
Philips (NYSE: PHG, AEX: PHIA) is a diversified health
and well-being company, focused on improving people's lives through
meaningful innovation in the areas of Healthcare, Consumer
Lifestyle and Lighting. Headquartered in the
Netherlands, Philips posted 2014 sales of EUR
21.4 billion and employs approximately 108,000
employees with sales and services in more than 100 countries. The
company is a leader in cardiac care, acute care and home
healthcare, energy efficient lighting solutions and new lighting
applications, as well as male shaving and grooming and oral
healthcare. News from Philips is located at www.philips.com/newscenter.
*
Device marketed for research applications only. Not for clinical
use. Not available for sale in Canada
** Pending 510(k).Not available for sale in
the U.S.A. Not
available for sale in Canada.
Source: Royal Philips
Related stocks: EuronextAmsterdam:PHIA NYSE:PHG
Related Links:
http://www.usa.philips.com